|
|
|
16.12.25 - 15:24
|
Ahlsell acquires Scandinox AB (Cision)
|
|
|
Ahlsell Sverige AB has signed an agreement to acquire all shares in Scandinox AB, a niche FlowTech specialist in industrial pipes and steel components. The company has five employees with an annual turnover of approximately 70 MSEK.
Since its founding in 1998, Scandinox AB has offered a broad range of stainless steel pipes, flanges, and bar materials to customers in, among others, the pulp and paper, oil, and nuclear power industries. The company operates a warehouse and office in Halmstad.
Through this acquisition, Ahlsell strengthens its FlowTech Solutions offering, gaining access to...
|
|
|
16.12.25 - 15:24
|
UK Unemployment Rate Rises (AFX)
|
|
|
LONDON (dpa-AFX) - The UK unemployment rate rose slightly in the three months to October, the Office for National Statistics said on Tuesday.The jobless rate climbed to 5.1 percent in the three mo......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.12.25 - 14:48
|
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 (GlobeNewswire EN)
|
|
|
Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the successful completion of patient enrollment for the second cohort in its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company's proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). The cohort consists of six patients, who were recruited rapidly across three premier clinical sites: Johns Hopkins University, Tel Aviv Sourasky Medical Center, and Hadassah Medical Center....
|
|
|
|
|
16.12.25 - 14:36
|
Cementos Pacasmayo S.A.A. Announced Today That the Swiss Company Holcim, the World′s Leading Cement Company, Has Signed an Agreement to Purchase Inversiones Aspi, of the Hochschild Group, Which Controls 50.01% of Cementos PACASMAYO (Business Wire)
|
|
|
LIMA, Peru--(BUSINESS WIRE)--Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) announced today that the Swiss company Holcim, the world's leading cement company, has signed an agreement to purchase Inversiones Aspi S.A. of the Hochschild Group, which controls 50.01% of Cementos PACASMAYO. The valuation of S/ 5,100 MM has been made at a multiple of nine times EBITDA based on the twelve-month period ending in September 2025, which set an all-time EBITDA record for the company. This transaction provides high profitability for shareholders, as it offers a significant premium over the Company's current market capitalization.
“We are very pleased and proud of this transaction. For 68 years, we have dedicated ourselves to our values, commitment, and history, always focused on our customers. Thanks to this dedication, we have built a strong brand and a world-class production and commercial operation that has positioned us among the most profitable cement com...
|
|
|
16.12.25 - 14:18
|
UK Private Sector Growth Improves In December (AFX)
|
|
|
LONDON (dpa-AFX) - The UK private sector activity expanded at a faster pace in December, led by the sharpest growth in new business in over a year, flash survey results from S&P Global revealed on......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alle News zu Großbritannien 9675.012 -0.81% (FTSE 100 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
